$124.370
+1.903 (+1.53%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Halozyme Therapeutics Inc (HALO) Moving Averages Convergence Divergence (MACD) indicator is 3.70, suggesting HALO is Strong buy.
Halozyme Therapeutics Inc (HALO) 20-Day simple moving average is 113.50, while Halozyme Therapeutics Inc (HALO) share price is $—, making it Buy.
Halozyme Therapeutics Inc (HALO) 60-Day simple moving average is 106.00, while Halozyme Therapeutics Inc (HALO) share price is $—, making it Buy.
Technical Analysis for HALO
AI Technical HALOAs of 2026-10-17, the technical board for Halozyme Therapeutics Inc (HALO) reads strong buy: 9 indicators are flashing buy, 2 are indicating sell, and 2 are neutral. Price at $124.37 sits above every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 73.106, MACD stands at 3.703 (Buy), Stochastic %K stands at 95.241 (Sell), Stochastic %D stands at 93.565 and CCI stands at 187.315 (Sell).
HALO trades above the 60-day SMA (106.00) and above the 200-day SMA (81.16). Immediate resistance sits at Classic R1 124.85, then R2 133.82. Support sits at Classic S1 107.16, then S2 98.44.
Halozyme Therapeutics Inc (HALO) Support & Resistance Level
Halozyme Therapeutics Inc (HALO) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 73.106 |
| STOCHk_14_3_3 | 95.241 |
| STOCHd_14_3_3 | 93.565 |
| CCI_20 | 187.315 |
| AO_5_34 | 8.782 |
| MOM_10 | 14.650 |
| MACD_12_26_9 | 3.703 |
Halozyme Therapeutics Inc (HALO) Relative Strength Index (RSI_14) is 73.106, creating a Sell signal.
Halozyme Therapeutics Inc (HALO) Stochastic %K is 95.241, creating a Sell signal.
Halozyme Therapeutics Inc (HALO) Stochastic %D is 93.565, creating a Sell signal.
Halozyme Therapeutics Inc (HALO) CCI_20 is 187.315, creating a Sell signal.
Halozyme Therapeutics Inc (HALO) Awesome Oscillator (AO) is 8.782, creating a Buy signal.
Halozyme Therapeutics Inc (HALO) Momentum (MOM) is 14.650, creating a Buy signal.
Halozyme Therapeutics Inc (HALO) Moving Average Convergence Divergence (MACD) is 3.703, creating a Buy signal.
Halozyme Therapeutics Inc (HALO) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 121.408 | Buy |
| MA_10 | 115.879 | Buy |
| MA_20 | 113.502 | Buy |
| MA_60 | 106.001 | Buy |
| MA_200 | 81.158 | Buy |
| MA_250 | 78.393 | Buy |
Halozyme Therapeutics Inc (HALO) 5-Day simple moving average is 121.408, while Halozyme Therapeutics Inc (HALO) share price is $, making it a Buy.
Halozyme Therapeutics Inc (HALO) 10-Day simple moving average is 115.879, while Halozyme Therapeutics Inc (HALO) share price is $, making it a Buy.
Halozyme Therapeutics Inc (HALO) 20-Day simple moving average is 113.502, while Halozyme Therapeutics Inc (HALO) share price is $, making it a Buy.
Halozyme Therapeutics Inc (HALO) 60-Day simple moving average is 106.001, while Halozyme Therapeutics Inc (HALO) share price is $, making it a Buy.
Halozyme Therapeutics Inc (HALO) 200-Day simple moving average is 81.158, while Halozyme Therapeutics Inc (HALO) share price is $, making it a Buy.
Halozyme Therapeutics Inc (HALO) 250-Day simple moving average is 78.393, while Halozyme Therapeutics Inc (HALO) share price is $, making it a Buy.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.